CG Oncology Inc. Common s...
(CGON)
undefined
undefined%
At close: undefined
30.80
3.60%
Pre-market Jan 07, 2025, 04:45 AM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 |
| PE Ratio | -3.31 | -69.88 | -192.92 |
| PS Ratio | 789.12 | 12.97K | 239.13 |
| PB Ratio | 0.87 | 19.79 | 61.53 |
| P/FCF Ratio | -3.52 | -83.07 | -180.12 |
| P/OCF Ratio | -3.52 | -83.11 | -181.4 |
| OCF/S Ratio | -223.92 | -156.04 | -1.32 |
| Debt / Equity Ratio | n/a | 0.12 | 0.37 |
| Quick Ratio | 13.62 | 9.54 | 9.78 |
| Current Ratio | 13.62 | 9.54 | 9.78 |
| Asset Turnover | 0.00 | 0.00 | 0.18 |
| Interest Coverage | n/a | -35.25K | -27.95 |
| Return on Equity (ROE) | -0.26 | -0.28 | -0.32 |
| Return on Assets (ROA) | -0.24 | -0.24 | -0.22 |
| Return on Capital (ROIC) | -0.3 | -0.27 | -0.24 |
| Dividend Yield | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a |
| Gross Profit Margin | 100.00% | 92.15% | 99.90% |
| Net Profit Margin | -23.83K% | -18.56K% | -123.95% |
| Pretax Profit Margin | -23.83K% | -18.56K% | -123.95% |
| Operating Profit Margin | -27.18K% | -18.45K% | -121.7% |
| FCF Margin | -22.39K% | -15.61K% | -132.76% |
| EBITDA Margin | -27.17K% | -18.45K% | -119.5% |